Search by Drug Name or NDC

NDC 17714-0115-10 Meclizine HCL 25 mg/1 Details

Meclizine HCL 25 mg/1

Meclizine HCL is a ORAL TABLET, CHEWABLE in the HUMAN OTC DRUG category. It is labeled and distributed by Advance Pharmaceutical Inc.. The primary component is MECLIZINE HYDROCHLORIDE.

MedlinePlus Drug Summary

Meclizine is used to prevent and treat nausea, vomiting, and dizziness caused by motion sickness. It is most effective if taken before symptoms appear.

Related Packages: 17714-0115-10
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Meclizine

Product Information

NDC	17714-0115
Product ID	17714-115_5cc96295-eaf6-1c2a-e053-2a91aa0a18b3
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Meclizine HCL
Proprietary Name Suffix	n/a
Non-Proprietary Name	Meclizine HCl 25mg Chewable Tablets
Product Type	HUMAN OTC DRUG
Dosage Form	TABLET, CHEWABLE
Route	ORAL
Active Ingredient Strength	25
Active Ingredient Units	mg/1
Substance Name	MECLIZINE HYDROCHLORIDE
Labeler Name	Advance Pharmaceutical Inc.
Pharmaceutical Class	Antiemetic [EPC], Emesis Suppression [PE]
DEA Schedule	n/a
Marketing Category	OTC MONOGRAPH FINAL
Application Number	part336
Listing Certified Through	2024-12-31

Package

Package Images

NDC 17714-0115-10 (17714011510)

Pricing Information	N/A
NDC Package Code	17714-115-10
Billing NDC	17714011510
Package	1000 TABLET, CHEWABLE in 1 BOTTLE (17714-115-10)
Marketing Start Date	2013-07-01
NDC Exclude Flag	N

Standard Product Labeling (SPL)/Prescribing Information SPL ef43c413-90a0-4d33-90a7-a29db3cdfa92 Details

Active ingredient

Meclizine Hydrochloride 25 mg

Purpose

Antiemetic

Uses

For the prevention and treatment of nausea, vomiting or dizziness associated with motion sickness. For other uses consult your doctor

Warnings

Ask a doctor before use if you have

glaucoma
a breathing problem such as emphysema or chronic bronchitis
trouble urinating due to an elarged prostate gland

Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers

When using this product

you may get drowsy
avoid alcoholic drinks
alcohol, sedatives and tranquilizers may increse drowsiness
be careful when driving a moor vehicle or operating machinery

Directions

take dose one hour before travel starts

tablets can be chewed or swallowed whole with water

adults & children 12 years and over:

take 1-2 tablets once daily

children under 12 years:

ask a doctor

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

OTHER INFORMATION

Phenylketonurics:

each tablet contains:

phenylalanine 0.28 mg

store at room temparature 15 - 30 °C

Questions or Comments

call 631-981-4600, 8.30 am-4.30 pm ET, Monday - Friday

TAMPER EVIDENT: DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING

Inactive ingredients

Aspartame, compressible sugar, croscarmellose sodium, dextrose, FD&C red 40 (al-lake), magnesium stearate, microcrystalline cellulose, raspberry flavor

Package/Label Principal Display Panel

INGREDIENTS AND APPEARANCE

MECLIZINE HCL

meclizine hcl 25mg chewable tablets tablet, chewable

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:17714-115
Route of Administration	ORAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
MECLIZINE HYDROCHLORIDE (UNII: HDP7W44CIO) (MECLIZINE - UNII:3L5TQ84570)	MECLIZINE HYDROCHLORIDE	25 mg

Ingredient Name	Strength
Inactive Ingredients
ASPARTAME (UNII: Z0H242BBR1)
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
DEXTROSE (UNII: IY9XDZ35W2)
FD&C RED NO. 40 (UNII: WZB9127XOA)
RASPBERRY (UNII: 4N14V5R27W)
MAGNESIUM STEARATE (UNII: 70097M6I30)
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
SUCROSE (UNII: C151H8M554)

Product Characteristics
Color	red	Score	2 pieces
Shape	ROUND	Size	8mm
Flavor	RASPBERRY	Imprint Code	AP;115
Contains

#	Item Code	Package Description	Marketing Start Date
Packaging
1	NDC:17714-115-01	100 in 1 BOTTLE; Type 0: Not a Combination Product	07/01/2013
2	NDC:17714-115-10	1000 in 1 BOTTLE; Type 0: Not a Combination Product	07/01/2013

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC monograph final	part336	07/01/2013

Labeler - Advance Pharmaceutical Inc. (078301063)

Registrant - Advance Pharmaceutical Inc. (078301063)

Name	Address	ID/FEI	Business Operations
Establishment
Advance Pharmaceutical Inc.		078301063	manufacture(17714-115)

Revised: 10/2017

Document Id: 5cc96295-eaf6-1c2a-e053-2a91aa0a18b3

Set id: ef43c413-90a0-4d33-90a7-a29db3cdfa92

Version: 2

Effective Time: 20171030